螺旋霉素在感染性疾病中的疗效

Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology) Pub Date : 2022-07-30 DOI:10.33920/med-13-2208-15

G. E. Khakberdieva, M. Bakhtiyorov

{"title":"螺旋霉素在感染性疾病中的疗效","authors":"G. E. Khakberdieva, M. Bakhtiyorov","doi":"10.33920/med-13-2208-15","DOIUrl":null,"url":null,"abstract":"In recent years, interest in macrolides has expanded significantly, primarily in infectious respiratory diseases treatment and due to an increase in the frequency of infections caused by intracellular microorganisms — chlamydia, mycoplasmas, and Helicobacter pylori. The aim: to evaluate spiramycin effectiveness in treating infectious diseases and assess its benefits and side effects in people with chronic comorbidities.","PeriodicalId":12259,"journal":{"name":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Spiramycin efficacy in infectious diseases\",\"authors\":\"G. E. Khakberdieva, M. Bakhtiyorov\",\"doi\":\"10.33920/med-13-2208-15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In recent years, interest in macrolides has expanded significantly, primarily in infectious respiratory diseases treatment and due to an increase in the frequency of infections caused by intracellular microorganisms — chlamydia, mycoplasmas, and Helicobacter pylori. The aim: to evaluate spiramycin effectiveness in treating infectious diseases and assess its benefits and side effects in people with chronic comorbidities.\",\"PeriodicalId\":12259,\"journal\":{\"name\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"volume\":\"53 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-13-2208-15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-13-2208-15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

近年来，由于细胞内微生物(衣原体、支原体和幽门螺杆菌)引起的感染频率增加，人们对大环内酯类药物的兴趣显著增加，主要是在感染性呼吸道疾病的治疗中。目的:评估螺旋霉素治疗感染性疾病的有效性，并评估其对慢性合并症患者的益处和副作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Spiramycin efficacy in infectious diseases

In recent years, interest in macrolides has expanded significantly, primarily in infectious respiratory diseases treatment and due to an increase in the frequency of infections caused by intracellular microorganisms — chlamydia, mycoplasmas, and Helicobacter pylori. The aim: to evaluate spiramycin effectiveness in treating infectious diseases and assess its benefits and side effects in people with chronic comorbidities.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)

自引率

0.00%

发文量